Literature DB >> 18535577

Bench to bedside: tempering antigen-presenting cells in multiple sclerosis.

Thomas Prod'homme, Scott S Zamvil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18535577     DOI： 10.1038/nm0608-614

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

Review 1.  Fibrinogen signal transduction in the nervous system.

Authors:  J K Ryu; D Davalos; K Akassoglou
Journal:  J Thromb Haemost       Date:  2009-07       Impact factor: 5.824

Review 2.  The Evolving Mechanisms of Action of Glatiramer Acetate.

Authors:  Thomas Prod'homme; Scott S Zamvil
Journal:  Cold Spring Harb Perspect Med       Date:  2019-02-01       Impact factor: 6.915

3.  Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.

Authors:  Ya Zhang; Xiaomei Zhang; Dongsheng Liu; Honghao Wang; Suyue Pan; Dongmei Wang; Xiong Chen
Journal:  Neurol Sci       Date:  2016-07-23       Impact factor: 3.307

Review 4.  Therapeutic decisions in multiple sclerosis: moving beyond efficacy.

Authors:  Wolfgang Brück; Raff Gold; Brett T Lund; Celia Oreja-Guevara; Alexandre Prat; Collin M Spencer; Lawrence Steinman; Mar Tintoré; Timothy L Vollmer; Martin S Weber; Leslie P Weiner; Tjalf Ziemssen; Scott S Zamvil
Journal:  JAMA Neurol       Date:  2013-10       Impact factor: 18.302

5.  Laquinimod, a quinoline-3-carboxamide, induces type II myeloid cells that modulate central nervous system autoimmunity.

Authors:  Ulf Schulze-Topphoff; Aparna Shetty; Michel Varrin-Doyer; Nicolas Molnarfi; Sharon A Sagan; Raymond A Sobel; Patricia A Nelson; Scott S Zamvil
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

Review 6.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14

7.  Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.

Authors:  Dimitrios Davalos; Jae Kyu Ryu; Mario Merlini; Kim M Baeten; Natacha Le Moan; Mark A Petersen; Thomas J Deerinck; Dimitri S Smirnoff; Catherine Bedard; Hiroyuki Hakozaki; Sara Gonias Murray; Jennie B Ling; Hans Lassmann; Jay L Degen; Mark H Ellisman; Katerina Akassoglou
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

8.  Glatiramer acetate treatment negatively regulates type I interferon signaling.

Authors:  Nicolas Molnarfi; Thomas Prod'homme; Ulf Schulze-Topphoff; Collin M Spencer; Martin S Weber; Juan C Patarroyo; Patrice H Lalive; Scott S Zamvil
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2015-11-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.